Categories
In the News Latest News Marketing

Earth Science Tech, Inc. (ETST) Announces Cancellation of 18,000,000 Common and 5,200,000 Preferred Shares, Updating the Outstanding Shares to 36,384,394 from 53,902,354

 Earth Science Tech Inc. (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces it has canceled 18,000,000 common shares along with 5,200,000 Series A Preferred shares through a confidential settlement with Majorca LTD, the majority shareholder. The Company now has zero preferred shares outstanding and 36,384,394 common shares outstanding which is down from 53,902,354.

ETST’s President, Director and Chairman Nickolas S. Tabraue stated, “We are extremely pleased to have reached a settlement with Majorca, LTD and the value it adds for our shareholders is immediately recognized and meaningful.”

Categories
In the News Latest News Top Stories

CBD and the Future of Sports Medicine

Why CBD is becoming the go-to for Athletes

Athletes are remarkable creatures. From a young age they show innate physical ability and continue to hone their skills through years of fierce dedication and hard work. Some go on to become world-class champions, record breakers and gold medalists and experience the kind of glory most of us can only dream of. But with glory comes injury and chronic pain. Pushing through punishing conditions takes its toll and for athletes, it’s what is expected.

And so it is, athletes get hurt A LOT —and turn around and go right back to competing. Eventually walking it off is no longer an option and they must deal with their ailments – everything from torn ligaments to broken bones and everything in between. They turn to doctors and coaches, most of whom inevitably point them down the path to pain medicine.

If taken too long, this practice can turn into over-reliance or over-indulgence; even addiction. It’s clear that professional and collegiate athletes are not immune to these dangers; if anything, they are more susceptible because they get hurt more often.

A Vicious Cycle

An over-reliance on painkillers and prescription drugs is nothing new. In the high-stakes game of professional sports, getting injured has far reaching consequences. Time away from the game can mean losing a position at the top, sponsorship or money– things that loom heavy on the minds of pro athletes everywhere.

It is no surprise that opioids and anti-inflammatories like NSAIDs are the first line of defense for athletes dealing with injury. While prescription medications have their place, there are a host of issues when used too frequently, namely a myriad of side effects and negative interactions with other substances.

Even anti-inflammatories at higher doses/frequency can be dangerous. In fact, the National Vital Statistics reported NSAID deaths as the 15th leading cause of death in the US. The longer-term health effects from anti-inflammatories (like naproxen) and opioids (like fentanyl) are equally grim and include cardiac health issues, kidney failure, and worsening respiratory conditions.

A New Option

Thankfully, many professional athletes and a few of the professional sports leagues around the world have started embracing alternative methods of pain relief like CBD.

CBD, the main non-psychoactive ingredient in cannabis, offers many impressive advantages over standard pain medicine such as no side effects, unusual interactions or risk of addiction – just to name a few.

CBD and other cannabinoids also work in tandem with the body’s own endocannabinoid system to achieve homeostasis, which further increases the body’s ability to recover and heal itself. Here are just a few of the many benefits athletes can expect from using CBD:

Help with inflammation – Inflammation is the most common type of pain athletes experience. CBD has long been associated with both anti-inflammatory and immunosuppressive qualities. Several studies show that cannabinoids downregulate cytokine and chemokine production and, in some models, upregulate T-regulatory cells (tregs) as a mechanism to suppress inflammatory responses.

Combat oxidative damage – CBD is a powerful antioxidant-, more powerful than Vitamins C and E. Cannabinoids have long been known to act as free radicals that help protect the brain and body and reverse oxidative injury.

Pain relief and muscle recovery – Pain relief is the number one reason athletes turn to CBD. It’s safer,less addictive and the neuroprotective and antispasmodic qualities help reduce muscle spasms. It also acts as an analgesic, which helps alleviate pain pre and post workout.

Chronic use of pain medication, even over-the-counter pain relievers, can create a host of problems. Not only is this country grappling with an opiate epidemic, but medical science is now uncovering many health risks associated with anti-inflammatories that were previously not known. Professional athletes are right to be concerned as they are one of the groups most susceptible to these dangers. It comes as no surprise that they have started actively seeking alternatives to pain relief and overall wellness, with CBD on the top of their list. (And with good reason!)

Shop Now

Categories
Feature Story In the News Latest News Top Stories Videos

ETST Premiered Kevin Harrington’s ‘As Seen On TV’ Infomercial Featuring Client Testimonial Has Commenced

DORAL, Florida, April 25, 2019 (GLOBE NEWSWIRE) — Earth Science Tech ( ETST) , an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, announces that its highly-anticipated As Seen On TV 60-second spot infomercial with esteemed entrepreneur Kevin Harrington began airing, April 23, 2019, in the New York City viewership area.

Filming of the infomercial, which was announced in early November, features one of the Company’s customers sharing her personal experience using ETST’s High Grade Full Spectrum Cannabinoids and its positive effect on her life. ETST’s infomercial has commenced airing April 23, 2019 and will continue to air in New York City viewership area between 9 p.m. and midnight EST., on Lifetime, the Cooking Channel and Fox News.

The Company chose New York City for its first market campaign because this exciting city is also one of the largest consumer-based areas in the U.S. and offers a growing number of placement locations to help expand ETST’s reach. The scheduling of additional infomercial spots for other markets, networks, and dates will be determined as the current marketing campaign progresses. ETST’s As Seen on TV infomercial will be aired through July 14, 2019, and can be viewed online and via social media.

View infomercial and As Seen On TV ETST page: (view here)

“I am really excited that we have completed production and are now able to share this Rhoda Friedman’s amazing story with the world,” ETST president, director and Chairman Nickolas S. Tabraue, said. “We are passionate about our products and the life-changing potential they offer. It’s a real pleasure to be involved with Kevin Harrington’s professional team as we aim to make a positive difference in the lives of our growing clientele.”

Earth Science Tech ( ETST 
Earth Science Tech ( ETST ) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market.  ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.

To learn more, please visit: www.EarthScienceTech.com

ETST currently has two wholly-owned subsidiaries and favored entity focused on developing its role as a world leader in the CBD space, expanding its work in the pharmaceutical and medical device sectors:

Earth Science Pharmaceutical, Inc. 
Earth Science Pharmaceutical (“ESP”) is a wholly-owned subsidiary of Earth Science Tech (ETST ), committed to the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP’s CEO and chief science officer, Dr. Michel Aubé, is leading the Company’s research and development efforts. The Company’s first medical device, Hygee™, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women. To learn more please visit: www.EarthSciencePharmaceutical.com

Cannabis Therapeutics, Inc.
Cannabis Therapeutics (“CTI”) is a wholly-owned subsidiary of Earth Science Tech ( ETST) poised to take a leadership role in the development of new, leading-edge cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol.  To learn more please visit: www.CannabisThera.com

Earth Science Foundation, Inc.
Earth Science Foundation (“ESF”) is a favored entity of Earth Science Tech ( ETST ) ESF is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech’s ( ETST) effective CBD products to those in need. To learn more please visit: www.ETSTFoundtion.org

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Categories
Cannabinoids Cannabis Events Cannabis Oils Cannabis Plant Feature Story Hemp Oil In the News Uncategorized

Cannabinoids, CBD and One Woman’s Journey with Multiple Sclerosis – A Personal Story

Ingrid was barely 26 years old when she was first diagnosed with multiple sclerosis (MS). The first sign something was amiss came when she was on vacation in the Dominican Republic in the early 1980’s. She woke up in her hotel room with double vision- in both eyes. She walked over to the mirror but all she could see was a hazy gray cloud staring back at her. She went to a nearby clinic in Santo Domingo but they didn’t really know what to tell her. After a general exam, they asked if she had insurance back home and recommended she see a doctor as soon as she got back. She had just had her first baby and decided not to tell my parents about the incident. When she landed in Miami, with her vision back intact, she dismissed the experience as a one-off and went back to work on Monday. Six months later she was driving home from work during the tail end of rush hour. She remembers the night was warm and the flickering brake lights reminded her of the dusky, setting sun. As the traffic around her came to a stop, she placed her foot on the brake, or tried to, but her leg did not respond. She tried again. Nothing. She recalls how terrifying it was realizing she could not move her leg, it was as though her brain and body were not connecting. And she was right. She slammed into the cars in front of her but luckily no one was seriously hurt. After that incident she went to a doctor, got a spinal tap and was diagnosed with multiple sclerosis.

And that is how, on a warm summer night, her journey with MS began- as well as our family’s journey with MS. For the next two decades my sister would be in remission. She worked a full time job (took the train to work) and managed to have three more children. She just became a grandmother in her 50’s, and has a large, loving and supportive family around her. But this progressive disease finally caught up to her. She is now unable to stand on her own or bathe herself independently and spends most days in a wheelchair in front of the television.

Cannabis has been used for medicinal purposes throughout centuries and is now recommended and prescribed to manage the symptoms of multiple sclerosis and other neurodegenerative diseases. I have been researching the beneficial effects of cannabis in multiple sclerosis for years but there is still much to be done in the way of education and clinical testing. Even so, anecdotal as well as many randomized placebo-controlled clinical trials have shown the efficacy of various cannabinoid treatments in managing spasticity, pain, bladder problems, sleep disturbances and tremor due to MS.

Every case of MS is different as is every person affected. Thankfully my sister does not suffer from pain-related symptoms. She’s had two seizures though, back to back in recent years and because of them has suffered some cognitive loss as well as other progressive symptoms like tremor and incontinence. She was able to obtain a license for medical marijuana this year and was prescribed a medicine which contained some THC, the main psychoactive component of cannabis.

She accepted the recommendation of the clinician without question or doubt. However, in no time we noticed some disturbing side effects. Things like short-term memory impairment, some disruption in her psycho-motor control and a somewhat weird, and distorted sense of time. For example, in July she asked where the Christmas decorations were. Around the same time, her caretaker reported panic on my sister’s part during a routine hair-washing session. This was unlike her and was clearly not the intended result and definitely not what we expected. I felt guilt having been the one to propose the idea that she start this regiment in the first place. What did I miss? It was a big anti-climactic disappointment; we had waited months for the license and had high hopes that it would bring her some relief. But the opposite occurred- this prescribed cannabis treatment not only didn’t work, it actually made her worse.

I knew that cannabinoids mimic naturally occurring compounds in the body called endocannabinoids. Endocannabinoids have been widely studied and implicated in a variety of physiological functions specifically with MS. When we take in cannabinoids, they interact with the same receptors found in all human cells. What I didn’t fully appreciate was that THC (tetrahydrocannabinol) affects the central nervous system (CNS) through these receptors- most densely in the frontal cortex and hippocampus. Cognition, especially in certain groups, such as patients suffering from diseases of the CNS like my sister, were particularly vulnerable to adverse effects.  However, some of the other constituents of cannabis, such as CBD (cannabidiol), have well-documented biological effects like anti-anxiety and anticonvulsive properties without any of the psychotropic actions. We realized that CBD might hold greater therapeutic potential for her than THC or any combination containing THC, since the psychoactive properties that accompany THC did not agree with her at all.  

We decided to give it one more shot and take matters into our own hands. We were on the lookout for a high quality- hemp derived, Full Spectrum CBD product. We were fortunate to find RAW, a high-grade, cannabinoid oil tincture. It contains unfiltered industrial full spectrum hemp oil, coconut MCT oil, and vitamin E as well as a variety of valuable phyto-nutrients, synergistic cannabinoids and essential oils. With RAW, we hit the jackpot. Not only did it work well, but it began working almost immediately.

One of my focuses of my freelance writing in the cannabis and medicinal marijuana space was to help my sister combat her MS symptoms and to help her live a fuller life. I saw that start to happen with RAW. As someone who does consistent research on the subject, I recommend this product as well as encourage everyone to do their own research.

From my experience, and from interviewing others, I understand that the manufacturing and selling of CBD products has become big business. I now know how to discern the differences between high quality products and subpar products as well as understand the different extraction methods available. Other finer points like the question of full spectrum vs. isolate products are important to understand before making a decision.

Ingrid began using RAW in the morning and at night, taking .5ml under her tongue, twice a day. After about a week she experienced less spasticity, less fatigue and tremor, and was just more alert and lucid. We have also seen a big improvement with her MS-related urinary symptoms. Her increased sense of well-being is also visible; the other day she commented that she “felt really strong”. When she visits her daughters, we pack ETS’s new veggie capsules in her overnight bag- we find that it’s easier for her to manage when she’s traveling.

We were concerned initially how this new regiment would interact chemically with her other prescribed drugs- but so far, she’s had no issues. We are thrilled, over the moon, and grateful that we didn’t give up. And you shouldn’t either. Cannabis derived compounds can hold real potential for those looking to treat symptoms of MS. The most important points to keep in mind are quality and consistency. You need to do your research, seek out the highest quality product you can find, and stay consistent with the dosing. For those looking to try any of EST’s products, the great news is you do not need a special marijuana card or prescription to do so.

Click here find out more about ETS.

Categories
In the News Latest News

2018 Cannabis Conference: Seeking Higher Ground

Philadelphia, Pennsylvania: Over 700 Gather for Philadelphia’s First Cannabis Opportunity Conferencehosted by Senator Street & DACO, Diasporic Alliance for Cannabis Opportunities

PHILADELPHIA, PA -‘2018 Cannabis Conference: Seeking Higher Ground’,PA Senator Sharif Street, 3rd District joined the Diasporic Alliance for Cannabis Opportunities(DACO) to host a two-day conference on the emerging opportunities in the Cannabis Industry for marginalized communities on Friday, October 19th and Saturday, October 20th, 2018 at Temple University Medical School located at 3500 N. Broad Street, Philadelphia, PA 19140.

 

The event which drew over 700 participants in two days was hosted by The Diasporic Alliance for Cannabis Opportunities and opened with a  welcome address by Philadelphia Mayor Jim Kenney and a message on Social Justice from US Senator Cory Booker. Senator Street and  DACO aims to open the dialogue for opportunities in education, wellness, social justice, policy, entrepreneurship and workforce development. A diverse group of exhibitors and speakers converged to offer a variety of programming including a job fair, legislative panel of past and pending cannabis reform, expungement clinic and more.

 

PA Senator Sharif Street (3rd District) added, “The issues of cannabis reform are economic issues, social justice issues and equity. The absurdity and history of US Drug Policy has been imbedded in the prohibition of cannabis and driven by the overincarceration of black and brown communities.  I am proud to offer legislation to decriminalize cannabis at the state level. I am proud to offer my office to constituents to sign up for Medical Marijuana cards and I am proud to join DACO in educating and empowering our communities to participate in this emerging industry. It is time for Pennsylvania to grow its economy and legalize cannabis in a fair, just and equitable way. ”

 

Cheron Perry-Thomas Co-founder and Chief Executive Officer, of the Diasporic Alliance for Cannabis Opportunities (DACO) said, “The 2018 Cannabis Opportunities Conference did what it set out to do which was to bring awareness of opportunities in cannabis to our communities.  Desiree Ivey and I have received much positive feedback about the education and networking opportunities. We were able to bring elected officials, experts, lawyers, doctors and community stakeholders together to ask questions, and learn about the cannabis as an entry to wellness and for economic empowerment.”

 

“The success of the very first Diasporic Alliance for Cannabis Opportunities Conference (DACO) shows nothing but how promising and beneficial this industry is on a number of levels – including medicinal, economic and entrepreneurial,” said Councilman Derek S. Green (At-Large). “I’m grateful to State Senator Sharif Street, as well as to the members of DACO for inviting me to be part of this endeavor. I look forward to future conversation and collaboration on this front.”

Categories
Feature Story Gonorrhea In the News Latest News Marketing Medical Sexually Transmitted Infections Top Stories

Earth Science Tech LTD (ETST) Promotes Women’s Health with Strategically Branded Self-sampling Kit

DORAL, Florida, Oct. 09, 2018 (GLOBE NEWSWIRE) —

Earth Science Tech LTD (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today details its branding strategy for Hygee™, a medical device designed for the detection of sexually transmitted infections (STIs) in women. With plans to market Hygee™ on five continents, ETST is deploying a striking graphic identity that will speak directly to women.

“From the name of the device to specifics of the logo, our branding strategy reflects the personal yet crucial nature of the Hygee™ self-sampling kit. We wanted to make the brand memorable, yet simple enough to promote its ease-of-use,” states Nickolas S. Tabraue, president, director and chairman of ETST. “Hygee™ is associated with peace of mind, protection, security, health and wellness.”A play on the Greek word for “hygiene,” the name Hygee™ integrates intimacy, confidentiality and discretion. Hygee™ looks like – and is worn like – a standard panty liner. Aptly named, the device allows a woman to discreetly take her own sample for testing to detect STIs, starting with chlamydia.

The positioning of “Personal feminine health test” explains the purpose of the product. Set under the logo, it gives the target market the context needed to better understand the brand.

The tagline, “Accurate, Simple and Discreet,” reflects the personal nature of the product.

ETST CEO and Chief Science Officer Dr. Michel Aubé said, “Hygee™ is designed to preserve women’s health. Our goal is to act upstream to give women the control and the information they need to avoid severe health complications from STI.”

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3330935c-ad09-415b-b662-94d805e17ceb

The Market

While STIs are a serious problem worldwide, the rates of infection across the USA have increased for the third consecutive year, according to the Centers for Disease Control and Prevention. The market for Hygee™ is considerable, as no one uses this technology to perform the 100 million tests for Chlamydia trachomatis done around the world each year. ETST believes Hygee™ will be an ideal tool for high throughput screening of individuals who want to know if they are infected with STIs like chlamydia and gonorrhea. It is accepted that young women are also at higher risk, and this is why ETST will market Hygee™ to target that demographic.

“The best way to fight STIs is prevention, and the only way for women to avoid the dangerous results of untreated STI is early treatment. This means that women need to know if they are infected. We believe that Hygee™ will be the best tool to provide that information. ETST will target specific populations of women globally to better counter the STI epidemic,” said Dr. Aubé.

About Earth Science Tech LTD (ETST)

Earth Science Tech LTD (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market.. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.

To learn more, please visit: www.earthsciencetech.com